Back to KRYS
FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. → KRYS
FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. KRYS Position History
Krystal Biotech, Inc. • Healthcare
Quarters held
1
Latest value
$3.6M
Q3 2026
Peak value
$3.6M
First seen
Q3 2026
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $3.6M | 10.8K | — | — |
Other funds holding KRYS
$537.3M
$502.2M
$502.2M
$339.5M
$78.2M
$78.2M